SRA737: Clinical Trials

2 trials of SRA737, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 22Completed 2

Follow SRA737: new trials by email Literature Review of SRA737 trials Research Report on SRA737

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer
SRA737 - Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)
Phase 1 / Phase 2CompletedSierra Oncology LLC - a GSK company1072016-07-012023-06-18
A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects
SRA737, gemcitabine, cisplatin, SRA737, gemcitabine - Advanced Solid Tumors
Phase 1 / Phase 2CompletedSierra Oncology LLC - a GSK company1532016-07-012023-06-22

Conditions studied

Fanconi Anemia (2)  ·  Anus Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Sarcoma (1)  ·  Small Cell Lung Carcinoma (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Sponsors

Sierra Oncology LLC - a GSK company (2)

Countries

United Kingdom (2)  ·  Spain (1)

Results publications

PMID 34665631, PMID 36378548, PMID 37120671